Mary Jeanne Kreek Selected Research

Cocaine (Cocaine HCl)

2/2022	Bidirectional influence of heroin and cocaine escalation in persons with dual opioid and cocaine dependence diagnoses.
1/2022	Analyses of polymorphisms of intron 2 of OPRK1 (kappa-opioid receptor gene) in association with opioid and cocaine dependence diagnoses in an African-American population.
1/2022	Kappa Opioid Receptor Antagonists as Potential Therapeutics for Mood and Substance Use Disorders.
1/2021	Association of Serotonin Transporter (SERT) Polymorphisms with Opioid Dependence and Dimensional Aspects of Cocaine Use in a Caucasian Cohort of Opioid Users.
1/2021	Age of onset of heaviest use of cannabis or alcohol in persons with severe opioid or cocaine use disorders.
11/2019	Genetic Variant in the CRH-binding Protein Gene (CRHBP) is Associated With Cessation of Cocaine Use in Methadone Maintenance Patients With Opioid Addiction.
1/2018	Re-evaluation of the KMSK scales, rapid dimensional measures of self-exposure to specific drugs: Gender-specific features.
1/2018	Repeated Administration of Opra Kappa (LY2456302), a Novel, Short-Acting, Selective KOP-r Antagonist, in Persons with and without Cocaine Dependence.
9/2017	Can a rapid measure of self-exposure to drugs of abuse provide dimensional information on depression comorbidity?
5/2017	Association of Variants of Arginine Vasopressin and Arginine Vasopressin Receptor 1A With Severe Acetaminophen Liver Injury.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mary Jeanne Kreek Research Topics

Disease

40	Opioid-Related Disorders (Opiate Addiction) 03/2022 - 01/2002
36	Cocaine-Related Disorders (Cocaine Addiction) 02/2022 - 05/2002
23	Alcoholism (Alcohol Abuse) 01/2022 - 02/2002
21	Heroin Dependence (Heroin Abuse) 01/2021 - 02/2003
20	Substance-Related Disorders (Drug Abuse) 01/2022 - 08/2004
9	Anhedonia 01/2022 - 01/2015
6	Pain (Aches) 01/2022 - 09/2003
4	Infections 03/2015 - 01/2002
4	Hepatitis C 09/2013 - 01/2002
3	Brain Diseases (Brain Disorder) 04/2020 - 02/2010
3	Tobacco Use Disorder (Nicotine Dependence) 03/2016 - 03/2003
2	Ataxia (Dyssynergia) 01/2022 - 01/2018
2	Liver Diseases (Liver Disease) 01/2022 - 02/2009
2	Chronic Pain 09/2021 - 07/2010
2	AIDS-Related Complex (ARC) 01/2019 - 06/2003
2	Mental Disorders (Mental Disorder) 01/2018 - 01/2006
2	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2018 - 04/2009
2	Inflammation (Inflammations) 08/2017 - 01/2014
2	Genetic Predisposition to Disease (Genetic Predisposition) 05/2015 - 01/2015
2	Shock 02/2015 - 01/2008
2	Cognitive Dysfunction 03/2013 - 10/2011
2	Hepatitis 09/2010 - 04/2008
2	Hepatitis A (Hepatitis, Infectious) 02/2009 - 04/2008
2	Hepatitis B 02/2009 - 04/2008
2	Coinfection 04/2008 - 01/2002
2	Hyperalgesia 10/2004 - 09/2003
1	Mood Disorders (Mood Disorder) 01/2022
1	Opiate Overdose 09/2021
1	Respiratory Insufficiency (Respiratory Failure) 09/2021
1	Obesity 01/2019
1	Marijuana Abuse (Cannabis Abuse) 01/2018

Drug/Important Bio-Agent (IBA)

27	Cocaine (Cocaine HCl)IBA 02/2022 - 10/2002
25	Opioid Analgesics (Opioids)IBA 02/2022 - 06/2002
24	Heroin (Diamorphine)IBA 02/2022 - 01/2002
24	Pharmaceutical PreparationsIBA 01/2022 - 05/2003
24	Methadone (Dolophine)FDA LinkGeneric 01/2021 - 01/2002
11	kappa Opioid Receptors (kappa Opioid Receptor)IBA 01/2022 - 12/2004
11	mu Opioid Receptors (mu Opioid Receptor)IBA 01/2021 - 02/2005
11	Opiate AlkaloidsIBA 03/2013 - 01/2002
10	Naltrexone (ReVia)FDA LinkGeneric 11/2020 - 02/2002
7	2-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA 01/2021 - 01/2002
5	preproenkephalinIBA 11/2020 - 05/2002
4	Narcotic Antagonists (Opioid Antagonists)IBA 09/2021 - 02/2002
4	Dynorphins (Dynorphin)IBA 05/2021 - 08/2003
4	Opioid Receptors (Opioid Receptor)IBA 01/2019 - 02/2003
3	LigandsIBA 01/2022 - 03/2013
3	TRK 820IBA 01/2022 - 01/2019
3	DNA (Deoxyribonucleic Acid)IBA 11/2020 - 04/2008
3	Buprenorphine (Subutex)FDA LinkGeneric 11/2020 - 02/2003
3	Oxycodone (Oxycontin)FDA LinkGeneric 01/2019 - 08/2017
3	salvinorin AIBA 01/2019 - 01/2015
3	RNA (Ribonucleic Acid)IBA 11/2018 - 04/2008
3	Dopamine (Intropin)FDA LinkGeneric 01/2018 - 12/2005
3	Morphine (MS Contin)FDA LinkGeneric 06/2012 - 03/2005
2	Naloxone (Narcan)FDA LinkGeneric 09/2021 - 11/2020
2	Fentanyl (Sublimaze)FDA LinkGeneric 09/2021 - 10/2004
2	Carrier Proteins (Binding Protein)IBA 01/2021 - 11/2019
2	nalmefene (Revex)FDA Link 01/2020 - 12/2005
2	Adrenocorticotropic Hormone (ACTH)FDA Link 11/2019 - 04/2009
2	Hormones (Hormone)IBA 11/2019 - 01/2018
2	3' Untranslated Regions (3' UTR)IBA 01/2019 - 04/2009
2	Long Noncoding RNAIBA 01/2019 - 01/2018
2	ProlactinIBA 01/2018 - 08/2003
2	AticaprantIBA 01/2018 - 01/2018
2	1- (5- chloro- 1- ((2,4- dimethoxyphenyl)sulfonyl)- 3- (2- methoxyphenyl)- 2- oxo- 2,3- dihydro- 1H- indol- 3- yl)- 4- hydroxy- N,N- dimethyl- 2- pyrrolidinecarboxamideIBA 01/2018 - 01/2008
2	Arginine Vasopressin (Argipressin)IBA 05/2017 - 02/2015
2	Analgesics (Analgesic Drugs)IBA 05/2017 - 07/2010
2	Proteins (Proteins, Gene)FDA Link 11/2015 - 06/2003
2	Biological ProductsIBA 06/2012 - 06/2002
2	Nicotine FDA Link 04/2009 - 03/2003
2	Corticotropin-Releasing HormoneIBA 04/2009 - 05/2003
2	Messenger RNA (mRNA)IBA 04/2009 - 01/2008
2	Capsaicin (Zostrix)FDA Link 10/2004 - 09/2003
1	Glutamate Receptors (Glutamate Receptor)IBA 03/2022
1	Anesthetics (Anesthetic Agents)IBA 09/2021
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2021
1	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 01/2021
1	Naloxone Drug Combination Buprenorphine FDA Link 11/2020
1	BenzodiazepinesIBA 11/2019
1	CRF receptor type 2IBA 01/2019
1	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 01/2019
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2019
1	activity regulated cytoskeletal-associated proteinIBA 01/2019
1	Mitogen-Activated Protein KinasesIBA 01/2019
1	Neuropeptide YIBA 01/2019
1	Bupropion (Wellbutrin)FDA LinkGeneric 01/2019
1	Sucrose (Saccharose)IBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	Medical MarijuanaIBA 01/2018
1	beta-Arrestin 1IBA 01/2018
1	N-benzoyl-N-phenylhydroxylamineIBA 01/2018
1	mesyl salvinorin BIBA 01/2018
1	Anti-Anxiety Agents (Anxiolytics)IBA 08/2017
1	Antidepressive Agents (Antidepressants)IBA 08/2017

Therapy/Procedure

5	Therapeutics 01/2022 - 02/2003
5	Drug Therapy (Chemotherapy) 01/2019 - 01/2002
3	Self Administration (Administration, Self) 11/2020 - 01/2008
3	Highly Active Antiretroviral Therapy (HAART) 03/2013 - 10/2011
2	Analgesia 01/2018 - 02/2011
1	Precision Medicine 01/2021